Safety of antithrombotic care in Dutch hospitals

Antithrombotic drugs belong to the most used medications in healthcare. About one in ten Dutch inhabitants uses them. Antithrombotic drugs reduce the risk of clot formation caused by pathologies such as atrial fibrillation or venous thromboembolism. Mitigating this risk comes at the cost of a small increase in the risk of bleeding. Often this trade-off is clear-cut and favours the use of antithrombotic drugs. However, in some cases these drugs can result in adverse events. Antithrombotic related adverse events (ARAEs) gained increasing attention in adverse event studies in the Netherlands in t... Mehr ...